KR101787393B1 - Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng - Google Patents

Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng Download PDF

Info

Publication number
KR101787393B1
KR101787393B1 KR1020170006289A KR20170006289A KR101787393B1 KR 101787393 B1 KR101787393 B1 KR 101787393B1 KR 1020170006289 A KR1020170006289 A KR 1020170006289A KR 20170006289 A KR20170006289 A KR 20170006289A KR 101787393 B1 KR101787393 B1 KR 101787393B1
Authority
KR
South Korea
Prior art keywords
red ginseng
mushroom
fermented product
mycelium
fermented
Prior art date
Application number
KR1020170006289A
Other languages
Korean (ko)
Inventor
홍인기
문동수
조일지
박진수
이혜정
이윤진
장경희
신대현
박성훈
차윤정
Original Assignee
주식회사 래디안
주식회사 코스모코스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 래디안, 주식회사 코스모코스 filed Critical 주식회사 래디안
Priority to KR1020170006289A priority Critical patent/KR101787393B1/en
Application granted granted Critical
Publication of KR101787393B1 publication Critical patent/KR101787393B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액(‘홍삼 발효물-치마버섯 배양액’을 함유하는 화장료 조성물에 관한 것으로, 본 발명의 ‘홍삼 발효물-치마버섯 배양액’은 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin), 세라마이드(Ceramide)발현 증가, 히알루론산 생성량 증가, 경피수분손실량 감소 및 수분함유량 증가효과를 나타내어 우수한 피부 보습 효과를 발휘하고, VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현을 증가시켜 우수한 피부 면역력 증가 효과를 발휘하며, NO 생성 억제, TNF-α 생성 억제, PGE2 생성 억제 효과를 나타내어 우수한 피부 염증 완화 효과를 발휘한다.The present invention relates to a culture solution ('cosmetic composition containing' red ginseng fermented product-skim milk culture solution ') obtained by inoculating and culturing mycelia of skimmed mushroom into fermented red ginseng fermented by inoculating a red ginseng powder with a mycelium of mycelia, The 'red ginseng fermented product-skimmer mushroom culture' of the present invention can be used for aquaporin-3, filaggrin, Increased expression of ceramide, increased hyaluronic acid production, reduced transdermal water loss, and increased water content resulted in excellent skin moisturizing effect and increased expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) , Exhibits an excellent effect of increasing skin immunity, exhibits an effect of inhibiting NO production, inhibiting TNF-α production, and inhibiting PGE 2 production, thereby exerting an excellent effect of reducing skin irritation.

Description

홍삼 발효물에 치마버섯 균사체를 배양하여 수득된 배양액을 함유하는 화장료 조성물{Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng}[0001] The present invention relates to a cosmetic composition containing a culture solution obtained by culturing a mycelia of mycelia of a skimmed mushroom in a fermented red ginseng product,

본 발명은 홍삼 발효물에 치마버섯 균사체를 배양하여 수득된 배양액을 함유하는 화장료 조성물에 관한 것으로, 좀 더 구체적으로는 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액을 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a culture solution obtained by culturing mycelia of mycelia of skins with a fermented product of red ginseng. More specifically, the present invention relates to a cosmetic composition comprising a red ginseng fermented product obtained by inoculating a red ginseng powder with a skimmed mushroom mycelial block, And a culture medium obtained by culturing the same.

치마버섯(Schizophyllum commume)은 분류학상으로 담자균류의 주름버섯목 느타리과 치마버섯속에 속하고, 야생에서 채취할 수 있으며, 자실체는 대가 없으며 갓의 측면이 기질에 부착하고 크기가 보통 1.0 ~ 3.0 ㎝이며, 모양은 부채형 또는 조개형이며 종으로 주름이 있고 말단은 불규칙하게 갈라지고 미세한 털이 덮혀 있다. 또한, 주름살은 백색이지만 성숙하게 되면 담회색 또는 담자갈색을 띄며, 조직은 건조한 경우 수축하게 되지만 수분을 흡수하면 회복되고, 포자문은 백색이고 포자는 4 ~ 6×1.5 ~ 2 ㎛의 크기의 원추형으로 평활하며 흰색을 띄고 있으며, 치마버섯은 활엽수림의 고목 또는 그루터기에 다발로 발생한다. Schizophyllum commume ) belongs to the wormy mushroom throat and chrysanthemum mushroom of the basidiomycetes and can be collected in the wild, and the fruiting bodies are free from stigma. The side of the gut is attached to the substrate and its size is usually 1.0 ~ 3.0 ㎝, It is a type or clamshell type with wrinkles, irregularly split ends and fine hairs. The wrinkles are white, but when mature, they become brownish brown or brownish brown. The tissue shrinks when dry, but when it absorbs moisture, it is restored. The whiteness is white and the spores are conical in size of 4 ~ 6 × 1.5 ~ 2 ㎛ Smooth and white. Skirt mushrooms occur on bundles of stumps or stumps of broadleaved forests.

최근에는 치마버섯과 관련된 여러 연구에서 치마버섯이 생산하는 베타글루칸 이라는 다당체가 여러 가지 다양한 효능이 있음이 밝혀지면서 이를 이용한 제품들이 출시되고 있다.Recently, several researches related to skim mushroom have revealed that the polysaccharide called betaglucan produced by skirt mushroom has various various effects, and products using the same are being released.

다만, 종래에는 대한민국 등록특허 제10-0654063호(베타-1,6-분지-베타-1,3-글루칸을 포접하여 안정화한 나노리포좀을 유효성분으로 함유하는 피부노화 방지용 화장료 조성물), 대한민국 공개특허 제10-2006-0031329호(베타-1,3-글루칸 및 해양심층수를 함유하는 피부탄력증진용 조성물)와 같이 치마버섯 베타글루칸을 단순히 유효성분으로 함유하여 피부 개선 효능을 발휘하는 화장료 조성물에 대한 것과 대한민국 등록특허 제10-909857호(베타-1,6-분지-베타-1,3-글루칸을 고농도로 생산하는 치마버섯 신균주 큐지143-1 및 당해 균주를 사용한 베타-1,6-분지-베타-1,3-글루칸의 제조방법)와 같이 치마버섯 유래 베타글루칸을 다량 생산하여 피부 개선 효능을 증진시키고자 하는 것이 대부분이었다.However, in the past, Korean Patent Registration No. 10-0654063 (cosmetic composition for preventing skin aging containing nanoliposome stabilized by beta-1, 6-branch-beta-1,3- Patent No. 10-2006-0031329 (a composition for enhancing skin elasticity containing beta-1,3-glucan and deep sea water), a cosmetic composition containing skim mushroom beta-glucan as an effective ingredient, Korean Patent No. 10-909857 (143-1, a new strain of chlamydomonas which produce beta-1,6-branched-beta-1,3-glucan at high concentration, and beta-1,6- The method for producing beta-1, 3-glucan), beta-glucan derived from skim mushroom was produced in large quantities to enhance the skin-improving effect.

한편, 치마버섯을 이용하여 피부 개선 효과를 발휘하는 소재로, 대한민국 등록특허 제10-1580107호에 치마버섯 균사체 발효 제비집 추출물이 개시되어 있으나, 아직까지 치마버섯 균사체를 이용하여 우수한 피부 개선 효과를 발휘하는 소재의 발굴이 더욱 필요한 실정이다.On the other hand, Korean Patent No. 10-1580107 discloses an extract of a fermented bird house fermented with mycelium of skim mushroom, which shows a skin improving effect by using a skirt mushroom. It is more necessary to excavate the material that it is.

본 발명의 발명자들은 치마버섯 균사체를 이용하여 우수한 피부 개선 효과를 발휘하는 소재에 대해 예의연구한 결과, 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액이 우수한 피부 염증 완화효과, 피부 면역력 증가효과, 피부 보습효과를 발휘함을 확인하고, 이를 함유하는 화장료 조성물을 제공하고자 한다.The inventors of the present invention have made intensive studies on materials exhibiting excellent skin improving effect by using mycelia of the skins of mushrooms. As a result, they have found that inoculation of mycelium of mycelium of skins with culture of fermented red ginseng fermented by inoculating mycelium block of skimmed mushroom to red ginseng powder, The present invention also provides a cosmetic composition containing the same. The present invention also provides a cosmetic composition containing the same, which is excellent in skin irritation alleviating effect, skin immunity increasing effect and skin moisturizing effect.

상기 목적을 달성하기 위하여, 본 발명은 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액을 함유하는 화장료 조성물을 제공한다. In order to achieve the above object, the present invention provides a cosmetic composition comprising a culture solution obtained by inoculating and culturing mycelia of skimmed mushroom in a red ginseng fermented product obtained by inoculating a red ginseng powder with a block of mycelia of mycelium of mycelia.

상기 본 발명의 홍삼 분말에 치마버섯 균사체 블록을 접종하여 고체 발효시켜 1차 발효된 홍삼 발효물에 치마버섯 균사체를 접종하고 배양함으로써 수득된 배양액은, 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin), 세라마이드(Ceramide)발현 증가, 히알루론산 생성량 증가, 경피수분손실량 감소 및 수분함유량 증가효과를 나타내어 우수한 피부 보습 효과를 발휘하고, VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현을 증가시켜 우수한 피부 면역력 증가 효과를 발휘하며, NO 생성 억제, TNF-α 생성 억제, PGE2 생성 억제 효과를 나타내어 우수한 피부 염증 완화 효과를 발휘한다.The culture solution obtained by inoculating the mycelial body of mycelia with the mycelia of the red ginseng powder of the present invention and inoculating the mycelia of the skimmed mushroom into the fermented red ginseng primary fermented by the solid fermentation and culturing was found to be Aquaporine- (Filaggrin), Increased expression of ceramide, increase of hyaluronic acid production, decrease of transdermal water loss, increase of water content, and exert excellent skin moisturizing effect and increase the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) , Exhibits an excellent effect of increasing skin immunity, exhibits an effect of inhibiting NO production, inhibiting TNF-α production, and inhibiting PGE 2 production, thereby exerting an excellent effect of reducing skin irritation.

한편, 본 발명에 있어서, 상기 치마버섯 균사체 블록은, 치마버섯 균사체가 착상되어 생장될 수 있는 지지체 (담체)에, 균사체가 접종되어 생장한 덩어리 상태를 지칭하는 것 한다. 일 예로 알지네이트 비드 또는 아가 비드에 치마버섯 균사체가 착상되어 생장한 것이 있다. On the other hand, in the present invention, the skirt mushroom mycelium block refers to a lump state in which a mycelium is inoculated on a support (carrier) on which a mycelium of mycelia of skins is conceived and can be grown. For example, some of the alginate beads or agar beads have been grown by implantation of mycelium of skimmed mushrooms.

상기 치마버섯 균사체 블록은 바람직하게 알지네이트 비드 또는 아가 비드를 이용하여 치마버섯 균사체가 알지네이트 비드 또는 아가 비드에 착상되도록 하고, 탄소원 또는 질소원을 첨가하여 치마버섯 균사체가 생장이 되도록 하여 제조할 수 있다. 좀 더 구체적으로 설명하면, 글루코스, 효모 추출물(yeast extract), 맥아 추출물(malt extract)을 조성한 후, 알지네이트 비드 및 아가 비드를 첨가한 다음 치마버섯 균사체를 접종하고 23 ~ 27℃에서 130 ~ 170 rpm으로 5 ~ 9일 동안 배양하여 제조될 수 있는 것이다.The skimmed mushroom mycelium block can be produced by allowing the mycelia of mycelia to be congruent with alginate beads or agar beads by using alginate beads or agar beads, and adding a carbon source or a nitrogen source to grow the mycelia of skim mushrooms. More specifically, after the addition of alginate beads and agar beads, glucose, yeast extract and malt extract were added, the mycelia of the skimmed mushrooms were inoculated, and the mixture was inoculated at 23 to 27 ° C at 130 to 170 rpm For 5 to 9 days.

한편, 본 발명에 있어서, 상기 홍삼 발효물은, 바람직하게 홍삼 분말에 치마버섯 균사체 블록을 접종하고, 22 ~ 26℃에서 3 ~ 7일간 발효시켜 제조되는 것이 좋다. 홍삼 발효물의 추출물에 치마버섯 균사체를 접종시켜 액상 발효시키면 베타글루칸과 같은 유용성분이 대량 생성된다.In the present invention, the red ginseng fermented product is preferably prepared by inoculating a red ginseng powder with a skins mushroom mycelium block and fermenting the mixture at 22 to 26 ° C for 3 to 7 days. When liquid fermentation is carried out by inoculating mycelia of skimmed mushroom into the extract of fermented red ginseng, a large amount of an ingredient such as beta-glucan is produced.

한편, 본 발명에 있어서, 상기 홍삼 발효물은, 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 것을 통칭하여 지칭하는데, 치마버섯 균사체 블록 또는 균사체를 함유하는 발효액을 포함하는 개념이며, 그 외에 발효액으로부터 치마버섯 균사체 블록 또는 균사체를 제거한 발효액을 포함하는 개념이기도 하며, 그 발효액을 건조시켜 제조한 분말을 포함하는 개념이기도 한다. In the present invention, the red ginseng fermented product is collectively referred to as fermented product obtained by inoculating a red ginseng powder with a layer of a mycelium of mycelium of mycelia, and is a concept including a fermentation liquid containing a mycelium block or a mycelium, And a fermentation broth in which a mycelium block or a mycelium is removed from the fermentation broth, and also includes a powder prepared by drying the fermentation broth.

한편, 상기 홍삼 발효물은, 바람직하게 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에 에탄올을 가하여 추출한 추출물인 것이 좋다. 홍삼 및 인삼 내 진세노사이드 같은 유효성분이 주로 물에 대한 용해도가 낮음으로 에탄올 추출로 인하여 그 추출 효율을 늘릴 수 있기 때문이다.The fermented product of red ginseng is preferably an extract obtained by adding ethanol to fermented red ginseng fermented by inoculating a red ginseng powder with a skins mushroom mycelium block. Since the active ingredient such as ginsenosides in red ginseng and ginseng is mainly low in solubility in water, the extraction efficiency can be increased by ethanol extraction.

더욱 바람직하게는 60 ~ 80%(v/v) 에탄올 수용액을 가하여 추출한 추출물인 것이 좋다. 60% 미만의 에탄올 수용액은 유효성분들의 추출 효율이 낮고 추출 시간 더욱 소요되며, 80% 초과의 에탄올 수용액은 불필요한 물질까지 추출될 수 있으며 그로 인한 제형 붕괴현상이 나타날 수 있다.More preferably, it is an extract obtained by adding 60 to 80% (v / v) aqueous ethanol solution. An aqueous solution of less than 60% ethanol has a low extraction efficiency of the active ingredients and requires more time for extraction, and an aqueous solution of more than 80% of ethanol can extract unnecessary substances, resulting in the disintegration of formulations.

한편, 본 발명에 있어서, 상기 배양은, 바람직하게 홍삼 발효물에 치마버섯 균사체를 접종하고, 23 ~ 27℃에서, 5 ~ 9일 동안 배양하는 것이 좋다. 이때, 상기 치마버섯 균사체는, 배양액 형태로 첨가할 수 있는데, 홍삼 발효물에 8 ~ 12%(v/v) 만큼 접종하는 것이 좋다. On the other hand, in the present invention, it is preferable to inoculate the mycelia of skins with the fermented product of red ginseng and preferably to cultivate at 23 to 27 DEG C for 5 to 9 days. At this time, the mycelia of the skim mushroom can be added in the form of a culture solution, and it is preferable to inoculate 8-12% (v / v) of the fermented red ginseng.

한편, 본 발명에 있어서, 상기 배양액은, 균사체가 제거된 여과액일 수 있다. 배양액에는 균사체가 존재하기 때문에 여과 후 화장료 조성물에 첨가하는 것이 바람직하다.On the other hand, in the present invention, the culture liquid may be a filtrate from which mycelium is removed. Since mycelium exists in the culture solution, it is preferable to add it to the cosmetic composition after filtration.

한편, 본 발명에 있어서, 상기 화장료 조성물은, 바람직하게 피부 염증 완화용, 피부 면역력 증가용 또는 피부 보습용일 수 있다. 본 발명의 실험예에 의하면 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin), 세라마이드(Ceramide) 발현 증가, 히알루론산 생성량 증가, 경피수분손실량 감소 및 수분함유량 증가효과를 나타내어 우수한 피부 보습 효과를 발휘하고, VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현을 증가시켜 우수한 피부 면역력 증가 효과를 발휘하며, NO 생성 억제, TNF-α 생성 억제, PGE2 생성 억제 효과를 나타내어 우수한 피부 염증 완화 효과를 발휘함을 확인하였다.On the other hand, in the present invention, the cosmetic composition may preferably be used for relieving skin irritation, for increasing skin immunity or for skin moisturizing. According to the experimental examples of the present invention, aquaporin-3, filaggrin, Increased expression of ceramide, increase of hyaluronic acid production, decrease of transdermal water loss, increase of water content, and exert excellent skin moisturizing effect and increase the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) And exhibited excellent skin immunity increasing effect, suppression of NO production, suppression of TNF-α production, and inhibition of PGE 2 production, thus demonstrating excellent skin irritation mitigation.

한편, 본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 '홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액' 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.On the other hand, the ingredients contained in the cosmetic composition of the present invention include, in addition to the 'culture solution obtained by inoculating and culturing mycelia of skimmed mushroom in a fermented product of red ginseng fermented by inoculating blocks of skimmed mushroom mycelium with red ginseng powder as an active ingredient, And include conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavoring agents, and carriers.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 팩, 마사지크림 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used in the form of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, , Oil, powdered foundation, emulsion foundation, wax foundation, pack, massage cream and spray, but is not limited thereto. More specifically, it can be manufactured in the form of a soft lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.

본 발명의 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide ether Alkylamido betaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester.

본 발명의 화장료 조성물이 비누, 계면활성제 함유 클렌징 제형 또는 계면활성제 비함유 클렌징 제형일 경우, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 구체적인 예로서, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클렌징 제형은 클렌징 폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비 함유 클렌징 제형은 클렌징크림, 클렌징 로션, 클렌징 워터 및 클렌징 겔이며, 이에 한정되는 것은 아니다.When the cosmetic composition of the present invention is a soap, a surfactant-containing cleansing formulation or a surfactant-free cleansing formulation, it may be applied to the skin and then wiped off, washed or rinsed with water. The surfactant-containing cleansing formulation may be a cleansing foam, a cleansing water, a cleansing towel and a cleansing pack. The surfactant-free cleansing formulation may be a cleansing cream, , Cleansing lotion, cleansing water and cleansing gel, but is not limited thereto.

본 발명은 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액(‘홍삼 발효물-치마버섯 배양액’)을 함유하여 피부 보습효과, 피부 면역력 증가효과, 피부 염증 완화효과를 발휘하는 화장료 조성물을 제공할 수 있다. 본 발명의 ‘홍삼 발효물-치마버섯 배양액’은 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin), 세라마이드(Ceramide) 발현 증가, 히알루론산 생성량 증가, 경피수분손실량 감소 및 수분함유량 증가효과를 나타내어 우수한 피부 보습 효과를 발휘하고, VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현을 증가시켜 우수한 피부 면역력 증가 효과를 발휘하며, NO 생성 억제, TNF-α 생성 억제, PGE2 생성 억제 효과를 나타내어 우수한 피부 염증 완화 효과를 발휘한다.The present invention includes a culture solution ('red ginseng fermented product - skim milk culture solution') obtained by inoculating and culturing mycelia of skimmed mushroom into fermented red ginseng fermented by inoculating a red ginseng powder with a skimmed mushroom mycelial block, A cosmetic composition exhibiting an immunity increasing effect and a skin irritation alleviating effect can be provided. The 'red ginseng fermented product-skimmer mushroom culture' of the present invention can be used for aquaporin-3, filaggrin, Increased expression of ceramide, increase of hyaluronic acid production, decrease of transdermal water loss, increase of water content, and exert excellent skin moisturizing effect and increase the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) , Exhibits an excellent effect of increasing skin immunity, exhibits an effect of inhibiting NO production, inhibiting TNF-α production, and inhibiting PGE 2 production, thereby exerting an excellent effect of reducing skin irritation.

도 1은 '홍삼 발효물-치마버섯 배양액'의 아쿠아포린-3(Aquaporin-3), 필라그린(Filaggrin) 발현 정도를 확인한 결과이다.
도 2는 '홍삼 발효물-치마버섯 배양액'의 세라마이드(Ceramide), 필라그린(Filaggrin) 발현정도를 확인한 결과이다.
도 3은 '홍삼 발효물-치마버섯 배양액'의 히알루론산 생성량을 확인한 결과이다.
도 4는 피부에 '홍삼 발효물-치마버섯 배양액' 도포 후, 시간 경과에 따른 경피수분손실량을 측정한 결과이다.
도 5는 피부에 '홍삼 발효물-치마버섯 배양액' 도포 후, 시간 경과에 따른 수분함유량을 측정한 결과이다.
도 6은 '홍삼 발효물-치마버섯 배양액'의 VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원) 발현도를 확인한 결과이다.
도 7은 '홍삼 발효물-치마버섯 배양액'의 NO 생성 저해능을 확인한 결과이다.
도 8은 ‘홍삼 발효물-치마버섯 배양액’의 TNF-α 생성 억제능을 확인한 결과이다.
도 9는 '홍삼 발효물-치마버섯 배양액'의 PGE2 생성률을 확인한 결과이다.
FIG. 1 shows the results of confirming the expression level of aquaporin-3 and filaggrin in 'red ginseng fermented product-skimmer mushroom culture solution'.
FIG. 2 shows the results of confirming the expression level of ceramide and filaggrin in 'red ginseng fermented product-skimmer mushroom culture'.
FIG. 3 shows the results of confirming the amount of hyaluronic acid produced in the 'red ginseng fermented product-skimmed mushroom culture solution'.
FIG. 4 is a result of measuring the amount of transdermal water loss with time after application of 'red ginseng fermented product-skimmer mushroom culture' to the skin.
FIG. 5 shows the result of measuring the moisture content with time after applying the 'red ginseng fermented product-skimmed mushroom culture solution' to the skin.
FIG. 6 shows the results of confirming the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) in 'red ginseng fermented product-skimmer mushroom culture solution'.
FIG. 7 shows the results of confirming the NO production inhibiting ability of the 'red ginseng fermented product-skimmer mushroom culture'.
FIG. 8 shows the results of confirming the ability of the 'red ginseng fermented product-skimmer mushroom culture solution' to inhibit TNF-α production.
FIG. 9 shows the results of confirming the PGE 2 production rate of the 'red ginseng fermented product-skimmer mushroom culture'.

이하, 본 발명의 구성을 하기 실시예를 통해 구체적으로 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.Hereinafter, the structure of the present invention will be described in detail with reference to the following examples. However, the scope of the present invention is not limited to the following embodiments, and includes modifications of equivalent technical ideas.

[실시예 1: '홍삼 발효물-치마버섯 배양액'의 제조][Example 1: Preparation of fermented red ginseng-skimmer mushroom culture]

이하 본 발명에서 '홍삼 발효물-치마버섯 배양액'은 홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에, 치마버섯 균사체를 접종하고 배양함으로써 수득되는 배양액을을 지칭하는 것으로 한다.In the present invention, the term 'red ginseng fermented product-skimmer mushroom culture solution' refers to a culture solution obtained by inoculating and cultivating mycelia of skimmed mushroom into fermented red ginseng fermented by inoculating a mycelium block of skimmed mushroom to red ginseng powder.

<치마버섯 균사체 블록 제조><Manufacture of mycelia of mycelia of skull mushroom>

글루코스(glucose) 0.4%, 효모 추출물(yeast extract) 0.4%, 맥아 추출물(malt extract) 1%를 조성한 후, 식용 알지네이트 비드(alginate bead) 및 아가 비드(agar bead)를 첨가한 다음 치마버섯 균사체를 접종하고 25℃에서 150 rpm으로 7일 동안 배양하여 치마버섯 균사체 블록을 제조하였다.After adding 0.4% of glucose, 0.4% of yeast extract and 1% of malt extract, alginate beads and agar beads were added, And cultured at 25 ° C and 150 rpm for 7 days to prepare a block of mycelia of skimmed mushroom.

<홍삼 발효물 제조><Preparation of red ginseng fermented product>

홍삼을 블랜더로 마쇄하여 제조된 홍삼 분말과 치마버섯 균사체를 동량(1:1)으로 혼합하고 24℃에서 5일간 발효하여 홍삼 발효물을 제조하였다.Red ginseng powder was mixed with 1: 1 mixture of red ginseng powder and skimmed mushroom produced by blending red ginseng with a blender and fermented at 24 ℃ for 5 days to prepare fermented red ginseng.

상기 제조된 홍삼 발효물 중량의 10배에 해당하는 70% 에탄올 수용액을 첨가하여 3시간 동안 교반추출한 후, 감압건조하여 에탄올을 모두 증발시켜 수상의 홍삼 발효물(= 홍삼 발효물의 추출물)을 회수하였다.A 70% ethanol aqueous solution corresponding to 10 times the weight of the fermented red ginseng was added thereto, stirred and extracted for 3 hours, and then dried under reduced pressure to evaporate all of the ethanol to recover the fermented product (= extract of fermented red ginseng) .

<홍삼 발효물-치마버섯 배양액 제조><Red ginseng fermented product - Preparation of culture of skimmed mushroom>

상기 홍삼 발효물의 추출물에 치마버섯 종균배양액 10%(V/V)를 접종한 다음 24℃에서 150 rpm으로 7일간 배양하여 '홍삼 발효물-치마버섯 배양액'을 제조하였다.The red ginseng fermented product was inoculated with a 10% (v / v) culture medium of Rhizoma mushroom seed culture and cultured at 24 ° C and 150 rpm for 7 days to prepare 'red ginseng fermented product-skimmer mushroom culture'.

상기 '홍삼 발효물-치마버섯 배양액'을 원심분리 하여 1차로 균체를 제거하고, 그 후 제균필터 여과하여 여과액을 수득한 후, 하기 실험예에서 사용하였다.The 'red ginseng fermented product-skimmer mushroom culture solution' was centrifuged to remove cells first, and then the filter was filtered to obtain a filtrate, which was used in the following Experimental Example.

[비교실시예 1: '홍삼-치마버섯 배양액'의 제조][Comparative Example 1: Preparation of 'Red ginseng-skimmer mushroom culture']

본 실시예에서는 홍삼 분말에 치마바섯 균사체 블럭을 접종하여 발효시킨 홍삼 발효물이 아닌 일반 홍삼 분말에 치마버섯 균사체를 배양하여 수득한 배양액을 제조하였다. 이하에서는 본 실시예에서 제조한 배양액을 '홍삼-치마버섯 배양액'이라고 지칭하였다.In this Example, a culture solution was prepared by culturing mycelia of skimmed mushroom in general red ginseng powder, which was not fermented by fermented red ginseng fermented by inoculating a block of mycelium of mycelia with red ginseng powder. Hereinafter, the culture solution prepared in this example was referred to as 'red ginseng-skim milk culture solution'.

[실험예 1: '홍삼 발효물-치마버섯 배양액'의 피부 보습 효능 평가][Experimental Example 1: Assessment of skin moisturizing effect of 'red ginseng fermented product-skimmed mushroom culture solution']

본 실험예에서는 '홍삼 발효물-치마버섯 배양액'의 피부 보습 효능을 확인하고자 하였다.In this experimental example, the skin moisturizing effect of 'red ginseng fermented product-skimmer mushroom culture solution' was examined.

(1) 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin)(1) Aquaporine-3, Filaggrin, 활성능 평가Bow performance evaluation

본 실험예에서는 '홍삼 발효물-치마버섯 배양액'의 보습 효능 효과를 평가하였다.In this experiment, the effect of moisturizing effect of 'red ginseng fermented product-skimmer mushroom culture solution' was evaluated.

HaCaT 세포를 60 mm 플레이트(plate)에 8×105 cells/㎖의 농도로 접종하고 37℃, 5% CO₂인큐베이터(incubator)에서 24시간 배양한 후 배지를 제거하였다. 그 후, 혈청이 포함되지 않은 배지를 이용하여 1%가 되도록 희석한 시료('홍삼 발효물-치마버섯 배양액', '홍삼-치마버섯 배양액')를 처리하여 37℃, 5% CO₂인큐베이터(incubator)에서 48시간 배양하여 배지를 모두 제거하고 DPBS로 2회 세척(washing)하였다. 그 후 RIPA buffer 200 ㎕를 넣고, 스크래퍼(scraper)로 긁어서 마이크로 튜브(micro tube)로 옮긴 다음 시린지(syringe)를 이용하여 30회 정도 서스펜션(suspension) 하였다. 그 후, 아이스(ice)에서 30분 정도 인큐베이션(incubation)하고 4℃, 14,000rpm에서 30분 원심분리하였다. 그 후, 수득된 상층액을 새로운 마이크로 튜브(micro tube)로 옮긴 후, 단백질 정량하여 웨스턴 블랏(Western blot)을 수행하고 다음과 같은 절차로 면역학적 블로팅(Immunoblotting)을 수행하여 아쿠아포린-3(Aquaporine-3), 필라그린(Filaggrin) 활성능을 평가하였다.HaCaT cells were inoculated on a 60 mm plate at a concentration of 8 × 10 5 cells / ml, cultured in a 5% CO 2 incubator at 37 ° C. for 24 hours, and then the medium was removed. Thereafter, a sample ('red ginseng fermented product-skimmer mushroom culture', 'red ginseng-skimmer mushroom culture') diluted to 1% with a serum-free medium was treated and incubated at 37 ° C in a 5% CO 2 incubator ) For 48 hours to remove all medium and wash twice with DPBS. Then, 200 μl of RIPA buffer was added, scraped with a scraper, transferred to a micro tube, and then suspended 30 times using a syringe. Then, the cells were incubated in ice for 30 minutes and centrifuged at 14,000 rpm for 30 minutes at 4 캜. Thereafter, the obtained supernatant was transferred to a new micro tube, followed by quantification of the protein, Western blotting, and immunoblotting in the following procedure to obtain aquaporin-3 (Aquaporine-3) and Filaggrin bow performance were evaluated.

① 트랜스퍼(Transfer)가 끝난 멤브레인(membrane)을 통에 담아 D.W와 TBS-T로 헹궈주었다.① Transfer membrane was transferred into a tube and rinsed with D.W and TBS-T.

② 5% 스킴 밀크(skim milk)로 2시간 블락킹(blocking) 하였다.② Blocked with 5% skim milk for 2 hours.

③ TBS-T를 이용해 10분씩 6회 워싱(washing) 하였다.3) Washing was performed 6 times for 10 minutes using TBS-T.

④ 5% BSA 용액에 1차 항체(antibody)를 1:1000으로 희석하여 4℃에서 오버나이트(overnight) 하였다.④ The primary antibody was diluted 1: 1000 in 5% BSA solution and overnight at 4 ° C.

⑤ TBS-T를 이용해 10분씩 6회 워싱(washing) 하였다.⑤ Washed 6 times for 10 minutes using TBS-T.

⑥ 5% 스킴 밀크(skim milk)에 2차 항체(antibody)를 1:3000으로 희석하여 1시간 동안 쉐이킹(shaking) 하였다.⑥ Secondary antibody was diluted 1: 3000 in 5% skim milk and shaked for 1 hour.

⑦ TBS-T를 이용해 10분씩 6회 워싱(washing) 하였다.⑦ Washed 6 times for 10 minutes using TBS-T.

⑧ ECL 용액(solution)을 멤브레인(membrane)에 충분히 적신 후 카세트(cassette)에 넣고 필름(film)을 올린 뒤 잘 눌러 주었다.⑧ The ECL solution was sufficiently wetted on the membrane, placed in a cassette, and the film was raised and pressed well.

⑨ 디벨러퍼(Developer)와 픽서(fixer)를 이용하여 현상하였다.⑨ Developed with developer and fixer.

실험결과, '홍삼 발효물-치마버섯 배양액'이 '홍삼-치마버섯 배양액' 보다 아쿠아포린-3(Aquaporin-3), 필라그린(Filaggrin)의 발현이 우수한 것을 확인할 수 있었다 (도 1). 도 1은 '홍삼 발효물-치마버섯 배양액'의 아쿠아포린-3(Aquaporin-3), 필라그린(Filaggrin) 발현 정도를 확인한 결과이다. As a result of the experiment, it was confirmed that the 'red ginseng fermented product-skimmer mushroom culture' was superior in the expression of aquaporin-3 and filaggrin than the 'red ginseng-skimmer mushroom culture solution' (FIG. FIG. 1 shows the results of confirming the expression level of aquaporin-3 and filaggrin in 'red ginseng fermented product-skimmer mushroom culture solution'.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 아쿠아포린-3(Aquaporin-3), 필라그린(Filaggrin) 발현이 우수하여, 우수한 피부 보습 효능을 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product-skimmer mushroom culture' exhibits excellent skin moisturizing effect because of its excellent expression of Aquaporin-3 and Filaggrin.

(2) 세라마이드(Ceramide), 필라그린(Filaggrin) 발현량 평가(2) Assessment of expression amount of ceramide, filaggrin

HaCaT 세포주를 100 ㎜ 디쉬(dish)에 48×105cells을 접종 후, 37℃, 5% CO2 인큐베이터(incubator)에서 24시간 배양 후 배지를 모두 제거하고 PBS를 이용하여 남아있는 배지를 제거하였다. 그 후, 혈청이 포함되지 않은 배지를 이용하여 1%, 2%가 되도록 희석된 시료('홍삼 발효물-치마버섯 배양액')를 웰(well) 당 5,000 ㎕씩 처리하여 준 후 37℃, 5% CO2 인큐베이터(incubator)에서 24시간 배양하였다. 그 후, 배지를 모두 제거하고 퀴아졸(Qiazol) 1 ㎖를 넣어준 후 스크래퍼를 이용하여 세포를 수거하여 1.7 ㎖ 튜브에 옮긴 후 다음과 같은 절차로 RT-PCR을 수행하였다.The HaCaT cell line was inoculated on a 100 mm dish at 48 × 10 5 cells, cultured at 37 ° C. in a 5% CO 2 incubator for 24 hours, and then the medium was removed and the remaining medium was removed using PBS . Then, 5,000 μl of each sample ('red ginseng fermented product-skimmed mushroom culture') diluted to 1% and 2% by using a serum-free medium was treated at 37 ° C and 5 in% CO 2 incubator (incubator) and incubated for 24 hours. Subsequently, the medium was removed, and 1 ml of Qiazole was added. Cells were collected using a scraper, transferred to a 1.7 ml tube, and then subjected to RT-PCR in the following manner.

① 볼텍스(Vortex)를 이용하여 잘 섞이게 한 후 실온에서 5분간 반응시킨 후 퀴아졸(Qiazol) 용량의 1/5의 클로로포름(Chloroform)을 넣었다.① After vortexing, the mixture was allowed to react at room temperature for 5 minutes, and chloroform (1/5 of the Qiazol capacity) was added.

② 볼텍스(Vortex)를 이용하여 15초간 섞은 후 실온에서 3분간 반응시킨 후 4℃, 12,000 rpm에서 15분간 원심분리하였다.② After mixing for 15 seconds using Vortex, the mixture was reacted at room temperature for 3 minutes and centrifuged at 4 ° C and 12,000 rpm for 15 minutes.

③ 클로로포름(Chloroform) 2배 용량의 상층액을 취하여 새로운 1.7 ㎖ 튜브에 옮겨담고 퀴아졸(Qiazol) 1/2 용량의 이소프로판올(Iso-propanol)을 넣은 후 볼텍스(vortex)를 이용하여 섞고 실온에서 10분간 반응시켰다.③ Chloroform The supernatant of double volume was transferred to a new 1.7-ml tube. Iso-propanol (1/2 volume) of Qiazol was added and mixed with vortex at room temperature. Lt; / RTI &gt;

④ 4℃, 7,500 ~ 12,000 rpm에서 10분간 원심분리하였다.④ Centrifuge at 4 ℃ for 7 minutes at 7,500 ~ 12,000 rpm.

⑤ 상층액을 버리고 퀴아졸(Qiazol) 사용한 용량만큼 75% 콜드-에탄올(cold-Ethanol)을 넣고 조심스럽게 피펫팅(pipetting) 하였다.⑤ The supernatant was discarded and carefully pipetted with 75% cold-ethanol as much as the used amount of Qiazol.

⑥ 4℃, 7,500 ~ 12,000 rpm에서 10분간 원심분리 한 다음 상층액을 버리고 펠렛(pellelt)을 건조시켰다.⑥ Centrifuge at 4 ℃, 7,500 ~ 12,000 rpm for 10 minutes, discard the supernatant and dry the pellelt.

⑦ UV-포토스펙트로미터(UV-phtospectrometer)를 이용하여 추출된 RNA를 정량하고 cDNA 합성 후 각각의 프라이머(primer)를 이용하여 PCR을 수행하였다.⑦ RNA was quantified using UV-phtospectrometer and cDNA was synthesized, and PCR was performed using each primer.

이때, 양성대조군으로는 EGF(Epidermal growth factor)를 사용하였다.At this time, EGF (Epidermal growth factor) was used as a positive control group.

실험결과, '홍삼 발효물-치마버섯 배양액'의 처리농도의 증가에 따라, 세라마이드(Ceramide), 필라그린(Filagrrin) 발현도가 증가함을 확인할 수 있었다 (도 2). 도 2는 '홍삼 발효물-치마버섯 배양액'의 세라마이드(Ceramide), 필라그린(Filaggrin) 발현정도를 확인한 결과이다.As a result of the experiment, it was confirmed that the ceramide and filagrrin expressions were increased with increasing the treatment concentration of 'red ginseng fermented product-skimmer mushroom culture' (FIG. 2). FIG. 2 shows the results of confirming the expression level of ceramide and filaggrin in 'red ginseng fermented product-skimmer mushroom culture'.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 세라마이드(Ceramide), 필라그린(Filaggrin) 발현을 증가시켜, 우수한 피부 보습 효능을 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product-skimmer mushroom culture solution' exhibits excellent skin moisturizing effect by increasing the expression of ceramide and filaggrin.

(3) 히알루론산 어세이(Hyaluronic acid assay)(3) Hyaluronic acid assay

CCD-986SK 세포를 6-웰 플레이트(well plate)에 1×105cells/㎖의 농도로 2 ㎖ 씩 분주하고 DMEM, 10% FBS, 1% 항체(Antibiotics)가 포함된 배지에서 37℃, 5% CO₂조건으로 24시간 배양하였다. 그 후, 각 시료(홍삼 발효물-치마버섯 배양액')를 0.1%, 0.5%, 1%로 처리하고 다음과 같은 절차로 'Hyaluronan Enzyme-Linked Immunosorbent assay kit'를 이용하여 히알루론산(hyaluronic acid, HA)의 양을 측정하였다.CCD-986SK cells were dispensed in a 6-well plate at a concentration of 1 × 10 5 cells / ml in a volume of 2 ml and cultured in DMEM, 10% FBS, 1% antibody (Antibiotics) % CO2 for 24 hours. Hyaluronic acid-linked immunosorbent assay kit (Hyaluronan Enzyme-Linked Immunosorbent Assay Kit) was used to treat 0.1%, 0.5%, and 1% of each sample (red ginseng fermented product- HA) was measured.

① 준비된 스탠다드(standard)와 샘플(sample)을 옐로우 U-바텀 플레이트(yellow U-bottom plate)에 웰(well) 당 100 ㎕씩 넣었다 (Blank control은 1X 희석제(Diluent)를 웰 당 150 ㎕, Zero HA control은 1X 희석제(Diluent)를 웰 당 100 ㎕ 씩 넣었다.)(1) Prepare standard and sample in a yellow U-bottom plate with 100 μl per well. (Blank control is 1 × diluent diluent 150 μl per well, The HA control was diluted with 100 μl of 1X diluent per well.

② 그 후, Blank control을 제외한 모든 웰에 working HA Detector를 웰 당 50 ㎕씩 넣고, 부드럽게 흔들어 섞어준 후 실링(sealing)하여 37℃에서 1시간 동안 인큐베이션(incubation) 하였다.② After that, 50 ㎕ of working HA detector per well was added to all wells except blank control, gently mixed by shaking, sealed, and incubated at 37 ° C for 1 hour.

③ 그 후, 인큐베이션 플레이트(Incubation plate)의 모든 웰에서 100 ㎕ 씩을 플레이트(plate)로 옮기고 부드럽게 테이핑(tapping)한 후 실링(sealing) 하여 4℃에서 30분 동안 인큐베이션(incubation) 하였다. (3) Then, 100 μl of each well of the Incubation plate was transferred to a plate, gently taped, sealed, and incubated at 4 ° C for 30 minutes.

④ 플레이트(plate)로 부터 모든 용액(solution)을 제거하고, 1X 워시 컨센트레이트(Wash Concentrate) 200 ㎕로 3회 워싱(washing)하였다 (이때, 워시 버퍼(wash buffer)를 완벽히 제거하였다).④ Remove all the solution from the plate and wash 3 times with 200 μl of 1X Wash Concentrate (Wash buffer was completely removed).

⑤ 각 웰에 워킹 엔자임(Working enzyme) 100 ㎕씩을 넣고, 흔들어 섞은 후 실링(sealing)하여 37℃에서 30분 동안 인큐베이션(incubation) 하였다.⑤ 100 ㎕ of working enzyme was added to each well, shaken, sealed, and incubated at 37 캜 for 30 minutes.

⑥ ④번 스텝(step)을 반복하였다.⑥ Repeat step ④.

⑦ 각 웰에 기질 용액(Substrate solution)을 100 ㎕씩 넣고 R.T 암조건에서 반응시켰다.⑦ 100 ㎕ of substrate solution was added to each well and reacted under R.T.

⑧ 반응 15분 후부터 405nm에서 흡광을 측정하였다 (15분, 30분, 45분).⑧ From 15 minutes after the reaction, the absorbance was measured at 405 nm (15 minutes, 30 minutes, 45 minutes).

⑨ 각 웰에 스탑 용액(Stop solution) 50 ㎕씩을 넣었다.⑨ 50 μl of stop solution was added to each well.

대조군으로는 EGF (Epidermal growth factor)를 사용하였고, 하기 수학식 1을 이용하여 Standard curve의 수식에 시료의 흡광값을 대입하여 얻은 값들의 control 대비 HA 생성량을 확인하였다.EGF (Epidermal Growth Factor) was used as a control group, and the amount of HA produced was compared with the control obtained by substituting the absorbance value of the sample into the formula of the standard curve using the following equation (1).

Figure 112017004526223-pat00001
Figure 112017004526223-pat00001

실험결과, '홍삼 발효물-치마버섯 배양액'의 처리농도의 증가에 따라, 히알루론산(HA) 생성량이 증가함을 확인할 수 있었다 (도 3). 도 3은 '홍삼 발효물-치마버섯 배양액'의 히알루론산 생성량을 확인한 결과이다.As a result of the experiment, it was confirmed that the amount of hyaluronic acid (HA) was increased with an increase in the treatment concentration of 'red ginseng fermented product-skimmer mushroom culture' (FIG. 3). FIG. 3 shows the results of confirming the amount of hyaluronic acid produced in the 'red ginseng fermented product-skimmed mushroom culture solution'.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 히알루론산의 생성을 증가시켜 우수한 피부 보습 효능을 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product-skim milk culture solution' increases the production of hyaluronic acid and exerts excellent skin moisturizing effect.

(4) 경피수분손실량 확인(4) Confirmation of transdermal water loss

'홍삼 발효물-치마버섯 배양액'을 피부에 도포한 후, tewameter(MPA system, Courage+Khazaka electronic GmbH, TM300)를 이용하여 경피수분손실량을 측정하였다.The amount of transdermal water loss was measured using a tewameter (MPA system, Courage + Khazaka electronic GmbH, TM300) after applying the 'red ginseng fermented product-skimmer mushroom culture' to the skin.

실험결과, '홍삼 발효물-치마버섯 배양액'을 적용했을 때 시간에 따른 경피수분손실량이 양성대조군인 히알루론산 1% 처리보다 더 감소함을 확인할 수 있었다 (도 4). 도 4는 피부에 '홍삼 발효물-치마버섯 배양액' 도포 후, 시간 경과에 따른 경피수분손실량을 측정한 결과이다.As a result of the experiment, it was confirmed that when the 'red ginseng fermented product-chima mushroom culture solution' was applied, the amount of transdermal water loss with time decreased more than that of the positive control hyaluronic acid 1% treatment (FIG. FIG. 4 is a result of measuring the amount of transdermal water loss with time after application of 'red ginseng fermented product-skimmer mushroom culture' to the skin.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 경피수분손실량을 감소시켜 우수한 피부 보습 효능을 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product - skim mushroom culture solution' exhibits excellent skin moisturizing effect by reducing the transdermal water loss.

(5) 수분함유량 확인(5) Checking the water content

'홍삼 발효물-치마버섯 배양액'을 피부에 도포한 후, coneometer(MPA system, Courage+Khazaka electronic GmbH, CM825)를 이용하여 수분함유량을 측정하였다.After applying the 'red ginseng fermented product-skimmed mushroom culture' to the skin, the moisture content was measured using a coneometer (MPA system, Courage + Khazaka electronic GmbH, CM825).

실험결과, '홍삼 발효물-치마버섯 배양액'을 적용했을 때 시간에 따른 수분함유량이 양성대조군인 히알루론산 1% 처리보다 더 증가함을 확인할 수 있었다 (도 5). 도 5는 피부에 '홍삼 발효물-치마버섯 배양액' 도포 후, 시간 경과에 따른 수분함유량을 측정한 결과이다.As a result of the experiment, it was confirmed that when the 'red ginseng fermented product-skimmer mushroom culture solution' was applied, the moisture content with time increased more than the 1% hyaluronic acid treatment which was a positive control group (FIG. FIG. 5 shows the result of measuring the moisture content with time after applying the 'red ginseng fermented product-skimmed mushroom culture solution' to the skin.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 수분함유량을 증가시켜, 우수한 피부 보습 효능을 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product - skim milk culture solution' increases moisture content and exerts excellent skin moisturizing effect.

[실험예 2: '홍삼 발효물-치마버섯 배양액'의 피부 면역력 증가효과 확인][Experimental Example 2: Identification of Skin Irritation Enhancement Effect of 'Red Ginseng Fermented Product-Skimmer Mushroom Culture']

본 실험예에서는 '홍삼 발효물-치마버섯 배양액'의 피부 면역력 증가효과를 확인하고자 하였다.In this experiment, the effect of 'red ginseng fermented product - skimmer mushroom culture' on skin immunity was examined.

면역 형광 염색법(Immunofluorescence Staining)을 이용하여 면역력 효능을 확인하였다 (Areca nut extract treatment down-regulates involucrin in normal human oral keratinocyte through P13K/AKT activation, Oral Oncology (2007) 43, 670679 Tseng. at al 의 면역 형광 염색법을 참고).Immunofluorescence staining was used to confirm the immunocompetent effect (Areca nut extract treatment down-regulates involution in normal human oral keratinocyte through P13K / AKT activation, Oral Oncology (2007) 43, 670679 Tseng. See staining).

실험결과, 1% '홍삼 발효물-치마버섯 배양액'의 경우, VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현도가 음성대조군보다 높고, 양성대조군(5% Minosidil)과 유사한 면역력 효능을 발휘함을 확인할 수 있었다 (도 6). 도 6은 '홍삼 발효물-치마버섯 배양액'의 VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원) 발현도를 확인한 결과이다. As a result, the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nucleus antigens) was higher than that of the negative control and the immunity similar to the positive control (5% Minosidil) in the case of 1% 'red ginseng fermented product - (Fig. 6). FIG. 6 shows the results of confirming the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nuclear antigen) in 'red ginseng fermented product-skimmer mushroom culture solution'.

상기와 같은 결과로부터, '홍삼 발효물-치마버섯 배양액'은 VEGF(혈관내피세포생장인자), PCNA(증식세포핵항원)의 발현을 증가시켜, 우수한 피부 면역력 증가 효과를 발휘함을 알 수 있었다.From the above results, it can be seen that the 'red ginseng fermented product-skimmer mushroom culture solution' exhibits an excellent skin immunity increasing effect by increasing the expression of VEGF (vascular endothelial cell growth factor) and PCNA (proliferation nucleus antigen).

[[ 실험예Experimental Example 3: '홍삼  3: 'Red ginseng 발효물Fermentation product -- 치마버섯Skirt mushroom 배양액'의 피부 항염 효과 확인] Culture solution '

본 실험예에서는 '홍삼 발효물-치마버섯 배양액'의 피부 항염 효과를 확인하고자 하였다.In this experimental example, the effect of 'red ginseng fermented product - skimmer mushroom culture solution' on skin was examined.

(1) NO의 생성 억제능 확인(NO assay)(1) Confirmation of NO production inhibition (NO assay)

활성질소종(Reactive nitric species, RNS)인 산화질소(nitric oxide, NO)의 과도한 생성은 염증반응을 유도하며, 이에 대한 효능 측정을 위하여 세포를 LPS (lipopolysaccharide)로 자극하여 NO의 생성을 유도한 후, '홍삼 발효물-치마버섯 배양액' 처리에 의한 NO 생성 저해효과를 그리스리간트(Griessreagent)법으로 측정하였다.Excessive production of nitric oxide (NO), which is a reactive nitric species (RNS), induces an inflammatory response and stimulates cells to produce NO by stimulating LPS (lipopolysaccharide) The inhibition of NO production by the treatment of 'red ginseng fermented product - skimmed mushroom culture' was measured by the Griessreagent method.

Raw 264.7 세포를 24-웰 플레이트(well plate)에 1×105 cells/㎖의 농도로 접종하고 37℃, 5% CO2 인큐베이터(incubator) 에서 24시간 배양하였다. 그 후, 적정 농도가 되도록 혈청이 포함되지 않은 배지 (LPS 100 ng/㎖ 포함)를 이용하여 희석한 시료(10, 20, 50 ㎍/㎖ '홍삼 발효물-치마버섯 배양액')를 500 ㎕씩 세포에 처리하였다. 24시간 배양한 후, 배지를 회수하여 4℃, 12,000rpm에서 10분간 원심분리를 시킨 후, 상층액만 회수하여 상층액 50 ㎕를 취한 다음 96-웰 플레이트(well plate)에 넣고 동량의 그리스리간트(Griessreagent)와 10분 동안 반응시킨 후, ELISA reader를 이용하여 540nm에서 흡광값을 측정하였다. 이때, 양성대조군으로 NMMA(NG-monomethyl-L-arginine)를 이용하였다.Raw 264.7 cells were inoculated in a 24-well plate at a concentration of 1 × 10 5 cells / ml and cultured in a 5% CO 2 incubator at 37 ° C. for 24 hours. Thereafter, 500 μl of a sample (10, 20, 50 μg / ml 'red ginseng fermented product - skim milk culture') diluted with a medium containing no serum (containing 100 ng / ml of LPS) Cells. After culturing for 24 hours, the medium was recovered and centrifuged at 4 ° C and 12,000 rpm for 10 minutes. Then, only the supernatant was recovered, and 50 μl of the supernatant was taken. Then, the supernatant was placed in a 96-well plate, After 10 minutes of reaction with Griessreagent, the absorbance was measured at 540 nm using an ELISA reader. At this time, NMMA (NG-monomethyl-L-arginine) was used as a positive control.

실험결과, '홍삼 발효물-치마버섯 배양액' 농도 의존적으로 NO 생성이 저해됨을 확인할 수 있었다 (도 7). 도 7은 '홍삼 발효물-치마버섯 배양액'의 NO 생성 저해능을 확인한 결과이다.As a result, it was confirmed that NO production was inhibited depending on the concentration of 'red ginseng fermented product-skimmer mushroom culture' (FIG. 7). FIG. 7 shows the results of confirming the NO production inhibiting ability of the 'red ginseng fermented product-skimmer mushroom culture'.

(2) TNF-α Immunoassay법을 이용한 항염 효능 평가(2) Evaluation of anti-inflammatory activity using TNF-α immunoassay

HaCaT 세포를 60mm 플레이트(plate)에 8×105 cells/㎖의 농도로 접종하고 37℃, 5% CO₂인큐베이터(incubator)에서 24시간 동안 배양한 후 배지를 제거하였다. 그 후, 혈청이 포함되지 않은 배지를 이용하여 희석한 시료(10, 20, 50 ㎍/㎖ '홍삼 발효물-치마버섯 배양액')를 처리하여 37℃, 5% CO2 인큐베이터(incubator)에서 48시간 배양하였다. 그 후, 배지를 회수하여 4℃, 12,000 rpm에서 10분간 원심분리를 시킨 후, 상층액만 회수하여 다음과 같은 절차로 TNF-α Immunoassay를 진행하였다.HaCaT cells were inoculated on a 60 mm plate at a concentration of 8 × 10 5 cells / ml, cultured in a 5% CO 2 incubator at 37 ° C. for 24 hours, and then the medium was removed. Thereafter, a sample (10, 20, 50 / / ml 'fermented red ginseng-skimmer mushroom culture'') diluted with serum-free medium was treated and incubated at 37 ° C in a 5% CO 2 incubator for 48 Time. After that, the culture medium was recovered and centrifuged at 12,000 rpm for 10 minutes at 4 ° C. Only the supernatant was recovered and subjected to TNF-α immunoassay as follows.

① 50 ㎕의 어세이 희석제(Assay Diluent) RD1F를 웰(well)에 넣었다. (1) Assay diluent (RD1F) of 50 μl was placed in a well.

② 200 ㎕의 상층액을 웰에 넣고 2시간 동안 실온에서 반응시켰다.② 200 μl of the supernatant was added to the well and reacted at room temperature for 2 hours.

③ 400 ㎕의 워시 버퍼(Wash buffer)를 이용하여 4회 웰을 씻어주었다.③ Wash the wells 4 times with 400 μl of wash buffer.

④ 200 ㎕의 TNF-α 컨쥬게이트(Conjugate)를 웰에 넣고 1시간 동안 실온에서 반응시켰다. ④ 200 μl of TNF-α conjugate was added to the well and reacted at room temperature for 1 hour.

⑤ 400 ㎕의 워시 버퍼(Wash buffer)를 이용하여 4회 웰을 씻어주었다. ⑤ Wash the wells 4 times with 400 μl of wash buffer.

⑥ 200 ㎕의 기질 용액(Substrate solution)을 웰에 넣고 20분간 암조건에서 반응시켰다. ⑥ 200 μl of Substrate solution was added to the well and allowed to react for 20 minutes under dark condition.

⑦ 50 ㎕의 스탑 용액(Stop solution)을 각 웰에 넣고 반응시켰다. ⑦ 50 ㎕ of stop solution was added to each well and reacted.

⑧ 450 nm 파장에서 TNF-α양을 흡광도로 측정하였다.⑧ The amount of TNF-α was measured by absorbance at 450 nm wavelength.

이때, 양성대조군으로 NMMA(NG-monomethyl-L-arginine)를 이용하였다.At this time, NMMA (NG-monomethyl-L-arginine) was used as a positive control.

실험결과, '홍삼 발효물-치마버섯 배양액' 농도 의존적으로 TNF-α 생성이 억제되었고, 특히 양성대조군인 NMMA보다 동등 이상의 효과를 발휘함을 확인할 수 있었다 (도 8). 도 8은 ‘홍삼 발효물-치마버섯 배양액’의 TNF-α 생성 억제능을 확인한 결과이다.As a result, it was confirmed that the TNF-α production was suppressed depending on the concentration of 'red ginseng fermented product-skimmer mushroom culture', and especially the same effect as that of NMMA, which is a positive control, was exerted (FIG. FIG. 8 shows the results of confirming the ability of the 'red ginseng fermented product-skimmer mushroom culture solution' to inhibit TNF-α production.

(3) ‘Immunoassay 시험법’을 이용한 PGE2 생성 억제 효능 평가(3) Evaluation of inhibitory effect of PGE 2 formation using 'Immunoassay test method'

HaCaT 세포 주를 24-웰 플레이트(well plate)에 1×105 cells/㎖의 농도로 접종하고 37℃, 5% CO2 인큐베이터(incubator)에서 24시간 동안 배양하였다. 그 후, 적정 농도가 되도록 혈청이 포함되지 않은 배지를 이용하여 희석한 시료(10, 20, 50 ㎍/㎖ '홍삼 발효물-치마버섯 배양액')를 세포에 처리하고 24시간 배양하였다. 그 후, 배지를 회수하여 4℃, 12,000 rpm에서 10분간 원심분리를 시킨 후, 상층액만 회수하여 다음과 같은 절차에 따라 ProstaglandinE2 Immunoassay를 수행하였다.HaCaT cell lines were inoculated in a 24-well plate at a concentration of 1 x 10 5 cells / ml and cultured in a 5% CO 2 incubator at 37 ° C for 24 hours. Thereafter, the samples (10, 20, and 50 / / ml 'fermented red ginseng-skimmer mushroom culture'') diluted with serum-free medium were cultured in the cells for 24 hours. Thereafter, the medium was recovered and centrifuged at 12,000 rpm for 10 minutes at 4 ° C. Only the supernatant was recovered and Prostaglandin E 2 Immunoassay was carried out according to the following procedure.

① 150 ㎕ 의 교정 희석제(Calibrator Diluent) RD5-56를 웰(well)에 넣었다. (1) 150 [mu] l of calibrator diluent RD5-56 was placed in a well.

② 150 ㎕의 상층액을 웰에 넣었다. ② 150 μl of the supernatant was added to the well.

③ 50 ㎕의 주된 항체 용액(Primary antibody solution)을 웰에 넣고 1시간 동안 실온, 오비탈 쉐이커(orbital shaker)(500 ±50 rpm)에서 반응시켰다. (3) 50 μl of the primary antibody solution was added to the wells and reacted at room temperature or orbital shaker (500 ± 50 rpm) for 1 hour.

④ 50 ㎕의 PGE2 컨쥬게이트(conjugate)를 웰에 넣고 2시간 동안 실온, 오비탈 쉐이커(orbital shaker)(500 ± 50 rpm)에서 반응시켰다. ④ 50 μl of PGE 2 conjugate was added to the well and allowed to react for 2 hours at room temperature or orbital shaker (500 ± 50 rpm).

⑤ 400 ㎕의 워쉬 버퍼(Wash buffer)를 이용하여 4회 웰을 씻어주었다. ⑤ Wash the wells 4 times with 400 μl of wash buffer.

⑥ 200 ㎕의 기질 용액(Substrate solution)을 웰에 넣고 20분간 암조건에서 반응시켰다. ⑥ 200 μl of Substrate solution was added to the well and allowed to react for 20 minutes under dark condition.

⑦ 10 ㎕의 스탑 용액(Stop solution)을 각 웰에 넣고 반응시켰다. ⑦ 10 μl of stop solution was added to each well and reacted.

⑧ 450 nm 파장에서 PGE2양을 흡광도로 측정하였다.⑧ The amount of PGE 2 was measured by absorbance at 450 nm wavelength.

이때, 양성대조군으로 NMMA(NG-monomethyl-L-arginine)를 이용하였다.At this time, NMMA (NG-monomethyl-L-arginine) was used as a positive control.

실험결과, '홍삼 발효물-치마버섯 배양액' 농도 의존적으로 PGE2 생성률이 감소됨을 확인하였고, 양성대조군인 NMMA보다 우수한 효과를 발휘함을 확인할 수 있었다 (도 9). 도 9는 '홍삼 발효물-치마버섯 배양액'의 PGE2 생성률을 확인한 결과이다.As a result of the experiment, it was confirmed that the production rate of PGE 2 was decreased depending on the concentration of 'red ginseng fermented product-skimmer mushroom culture', and it was confirmed that it exerts superior effect than the positive control NMMA (FIG. 9). FIG. 9 shows the results of confirming the PGE 2 production rate of the 'red ginseng fermented product-skimmer mushroom culture'.

Claims (10)

홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에,
치마버섯 균사체를 추가 접종하고 배양함으로써 수득되는 배양액을 함유하는 화장료 조성물.
To the fermented red ginseng fermented by inoculating mycelium block of skimmed mushroom into red ginseng powder,
A cosmetic composition comprising a culture obtained by further inoculating and culturing mycelia of skimmed mushrooms.
제1항에 있어서,
상기 치마버섯 균사체 블록은,
알지네이트 비드 또는 아가 비드에 치마버섯 균사체가 착상되어 생장한 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The skirt mushroom mycelium block comprises:
Wherein the alginate beads or agar beads are implanted with a mycelium of mycelia.
제1항에 있어서,
상기 홍삼 발효물은,
홍삼 분말에 치마버섯 균사체 블록을 접종하고 22 ~ 26℃에서 3 ~ 7일간 발효시켜 제조되는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The red ginseng fermented product,
Wherein the red ginseng powder is inoculated with a mycelium block of skimmed mushrooms and fermented at 22 to 26 DEG C for 3 to 7 days.
제1항에 있어서,
상기 홍삼 발효물은,
홍삼 분말에 치마버섯 균사체 블록을 접종하여 발효시킨 홍삼 발효물에 에탄올을 가하여 추출한 추출물인 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The red ginseng fermented product,
Wherein the extract is an extract obtained by adding ethanol to fermented red ginseng fermented by inoculating mycelium block of skimmed mushroom powder to red ginseng powder.
제1항에 있어서,
상기 배양은,
홍삼 발효물에 치마버섯 균사체를 접종하고, 23 ~ 27℃에서, 5 ~ 9일 동안 배양하는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The above-
Wherein the fermented red ginseng product is inoculated with mycelia of skimmed mushrooms and cultured at 23 to 27 DEG C for 5 to 9 days.
제5항에 있어서,
상기 치마버섯 균사체는,
배양액 형태로 홍삼 발효물에 8 ~ 12%(v/v) 만큼 접종하는 것을 특징으로 하는 화장료 조성물.
6. The method of claim 5,
Wherein the mycelia of the skim-
(V / v) to the fermented red ginseng in the form of a culture.
제1항에 있어서,
상기 배양액은,
균사체가 제거된 여과액인 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
Preferably,
Wherein the filtrate is a filtrate from which mycelium is removed.
제1항에 있어서,
상기 화장료 조성물은,
피부 염증 완화용인 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
In the cosmetic composition,
Wherein the cosmetic composition is for skin inflammation relief.
삭제delete 제1항에 있어서,
상기 화장료 조성물은,
피부 보습용인 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
In the cosmetic composition,
Wherein the composition is for moisturizing the skin.
KR1020170006289A 2017-01-13 2017-01-13 Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng KR101787393B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170006289A KR101787393B1 (en) 2017-01-13 2017-01-13 Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170006289A KR101787393B1 (en) 2017-01-13 2017-01-13 Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng

Publications (1)

Publication Number Publication Date
KR101787393B1 true KR101787393B1 (en) 2017-10-19

Family

ID=60298433

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170006289A KR101787393B1 (en) 2017-01-13 2017-01-13 Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng

Country Status (1)

Country Link
KR (1) KR101787393B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109464316A (en) * 2019-01-07 2019-03-15 广州市拓瑞科技有限公司 Skin conditioning composition, Medical cold application with antiallergic anti-inflammatory effect and preparation method thereof
CN109528569A (en) * 2019-01-07 2019-03-29 广州市拓瑞科技有限公司 Skin conditioning composition, cell maintenance essence dew with cell maintenance function and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109464316A (en) * 2019-01-07 2019-03-15 广州市拓瑞科技有限公司 Skin conditioning composition, Medical cold application with antiallergic anti-inflammatory effect and preparation method thereof
CN109528569A (en) * 2019-01-07 2019-03-29 广州市拓瑞科技有限公司 Skin conditioning composition, cell maintenance essence dew with cell maintenance function and preparation method thereof

Similar Documents

Publication Publication Date Title
JP5467106B2 (en) Cosmetic composition for preventing skin aging containing mung bean fermentation-enzyme extract
EP3646851A2 (en) Anti-aging composition comprising lactic acid bacteria-derived extracellular vesicle
KR101826145B1 (en) Saccharomyces cerevisiae HEH EHWA and Autolysis Extract Manufactured Using Thereof
KR101440469B1 (en) Method of fermented wild ginseng root using complex strains and cosmetic composition comprising thereof
KR101998032B1 (en) Cosmetic Composition for Improving Skin Condition Comprising Rosa Damascena Callus Culture Extract or the fermented filtrates to improve periorbital wrinkles, skin brightness and calm troubled skin
KR101770140B1 (en) Lactobacillus fermentum HK and Phormium tenax Fermented extract Manufactured Using Thereof
KR102171174B1 (en) Cosmetic and pharmaceutical applications of lactobacillus pentosus
KR101787393B1 (en) Cosmetic composition with the cultivated medium of Schizophyllum commume mycelium with fermented red ginseng
TWI388343B (en) Cosmetic composition for anti-aging of the skin comprising phaseolus radiatus extract of fermentation-enzyme treatment
KR101895174B1 (en) Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same
KR20170006466A (en) Cosmetic Composition for Improving Skin Wrinkle Comprising the Fermented Extract of Morinda citrifolia as Active Ingredient
KR101737940B1 (en) Composition of skin external application containing fermented soybean leaves extract
KR102119524B1 (en) Cosmetic composition comprising the extract of fermented Sprout leaf/stem ginseng for skin anti-wrinkle effect and producing method thereof
KR101749657B1 (en) Cosmetic Composition Comprising Fermented product of Dendropanax morbifera Sap as Active Ingredient
CN116240259A (en) Method for extracting compound from ginseng, ginseng extract containing the compound, and composition for enhancing skin barrier containing the same
KR20210107724A (en) rosewood extract
KR20170095461A (en) Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same
KR20200054590A (en) Composition for improving skin barrier comprising precipitation of fermented rice bran as active ingredient
KR20160118592A (en) Cosmetic Composition Containing Fermentative Extract of Chenopodium quinoa Willd as Active Ingredient
KR102344701B1 (en) Cosmetic composition having high functional natural fermentation extracts
KR20220093477A (en) Cosmetic composition for anti-aging containing prunus yedoensis flower biorenovate extract
CN114246822A (en) Micro-ecological composition for repairing and anti-aging skin and preparation method and application thereof
KR102021322B1 (en) A cosmetic composition containing fermented broussonetia kazinoki siebold and setaria italica and the method thereof
KR101965250B1 (en) Cosmetic composition for anti-oxidation, anti-inflammatory and anti-wrinkling containing enzyme-treated extracts of kakadu plum and manufacturing method of extract
KR102018883B1 (en) A cosmetic base material composition a fermentation products of rubus coreanus using phellinus baumii mycelium and a functional cosmetic composition comprising the same

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant